Tuesday, November 10, 2026
spot_img

Don't Miss

Clinical Trials

Allergan Aesthetics reports improved facial satisfaction in two Phase 4 studies of GLP-1 users

0
Allergan Aesthetics, an AbbVie company, has reported positive patient-reported outcomes from two Phase 4 studies evaluating aesthetic treatments in adults taking GLP-1 medications. The...

Galderma secures Chinese approval for Relfydess to treat glabellar lines

ES Aesthetic Solutions introduces NouVys collagen-peptide injectable to UK market

Dermalux launches at-home LED device for neck and décolletage

FACTORFIVE introduces DCA-based Renew Dermal Solution

Clinical Trials

Clinical Trials

Allergan Aesthetics reports improved facial satisfaction in two Phase 4 studies of GLP-1 users

0
Allergan Aesthetics, an AbbVie company, has reported positive patient-reported outcomes from two Phase 4 studies evaluating aesthetic treatments in adults taking GLP-1 medications. The...
Clinical Trials

Galderma reports positive results for Restylane Volyme in temple hollowing

0
Galderma has reported positive topline results from a 162-patient Chinese study of Restylane Volyme, known as Restylane Contour in the U.S., for the correction...

Ourself study finds single regenerative serum outperforms three-product skincare regimen

Allergan Aesthetics receives positive CHMP opinion for Boey across Europe

Lumenis Aesthetics showcases new clinical data across skin and hair loss indications

Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial

EVENTS

Funding

- Advertisement -

Featured

Latest Reviews

Clinical Trials

Allergan Aesthetics reports improved facial satisfaction in two Phase 4 studies of GLP-1 users

0
Allergan Aesthetics, an AbbVie company, has reported positive patient-reported outcomes from two Phase 4 studies evaluating aesthetic treatments in adults taking GLP-1 medications. The...

Galderma secures Chinese approval for Relfydess to treat glabellar lines

ES Aesthetic Solutions introduces NouVys collagen-peptide injectable to UK market

Mergers & Acquisitions

Galderma agrees to acquire ZO Skin Health for $1.5B to strengthen its medical-grade skincare portfolio

0
Galderma has signed an agreement to acquire ZO® Skin Health for $1.5 billion, expanding its presence in the physician-dispensed skincare market. The brand generated...

Cytrellis partners with KoreAx to commercialize ellacor in South Korea

0
Cytrellis Biosystems has partnered with KoreAx Co. Ltd. to commercialize ellacor Micro-Coring technology in South Korea, marking the company’s second major international market expansion...

ACRE expands portfolio through new distribution partnerships

0
Aesthetic distributor ACRE has announced new distribution partnerships with IBSA Derma and ZO Skin Health, strengthening its presence in the UK medical aesthetics market. Get...

MRP signs exclusive US distribution agreement to bring Vydence Medical platforms to market

0
Medical Resource Partners (MRP) has entered an exclusive U.S. distribution agreement with Brazil-based Vydence Medical to bring three energy-based aesthetic platforms to the U.S....

Evolus partners with IBSA to bring Profhilo to the U.S.

0
Evolus has entered an exclusive licensing and distribution agreement with IBSA to develop and commercialize Profhilo® in the United States, expanding its injectable aesthetics...
- Advertisement -
Advertismentspot_imgspot_img
Advertismentspot_imgspot_img

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Driving Growth in Aesthetics Globally

Over the past decade, we have successfully sourced talent for 40+ Medical Aesthetics companies across 20+ countries, completing over 350+ searches. Leveraging our extensive network and deep industry expertise, we have supported businesses at various growth stages, driving innovation in the sector.

Contact us: contact@ValuraNova.com